Sponsor content
68 result(s) found, displaying 31 to 40
-
Australian public assessment report (AusPar)Australian Public Assessment Report for BNT162b2 (mRNA)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Gemtuzumab ozogamicin
-
Australian public assessment report (AusPar)New AusPAR for Vyndamax (tafamidis) and Vyndaqel (tafamidis meglumine) for the treatment of transthyretin amyloid cardiomyopathy
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Bevacizumab
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Ceftazidime/Avibactam
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Talazoparib (as tosilate)
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Lorlatinib
-
Australian public assessment report (AusPar)Australian Public Assessment Report for Tofacitinib (as citrate)
-
Australian public assessment report (AusPar)Australian public assessment report for Crisaborole
-
Australian public assessment report (AusPar)Australian Public Assessment for Tofacitinib (as citrate)